Malin Corporation | MLC - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Akebia Therapeutics USD 24.75M 11.64M 2026-06
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
ALKERMES USD 1.48B 7.23M 2026-06
Avita Medical AUD 42.24M 1.25M 2024-12
Dianthus Therapeutics USD 0 0 2024-12
Eurofins Scientific SE EUR 3.7B 5M 2026-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
IQVIA Holdings USD 13.7B 284M 2026-06
Lonza CHF 3.88B 323M 2025-12
Malin Corporation EUR 0 0 2024-12
Moderna USD 597M 6M 2026-06
Organon & Co USD 8.48B 74M 2026-06
Ovoca Bio EUR 0 0 2021-06
Revvity USD 2.63B 1.02M 2026-06
Tectonic Therapeutic USD 17K 26K 2026-03
Viatris USD 11.61B 801.1M 2026-06
Xeris Pharmaceuticals USD 188.81M 32.42M 2026-06